Role of Prostate Specific Antigen in the Diagnosis of Prostate Carcinoma
Tie Li
Abstract
Tie Li
Abstract
Objective: To study the role of serum prostate specific antigen (PSA) and prostate specific antigen density (PSAD) in the diagnosis of prostate carcinoma.Methods: PSA and PSAD by means of ELISA technique were assayed and compared in 20 prostate carcinoma patients and in 30 benign prostatic hyperplasia.Results: When the upper normal limit of PSA was set at 4ng/ml, the diagnosic sensitivity was 90.0%, the specificity 53.3% and the accuracy 68.0% in prostate carcinoma. If the upper normal limit of PSA was set at 10ng/ml, the sensitivity,specificity and the accuracy were 80.0%,83.3% and 82.0% respectively. The diagnosis sensitivity of PSAD was 85.0%, the specificity 86.7% and the accuracy 86.0%.Conclusion: PSA assay is the important means to discover prostate carcinoma and PSAD seems to be more reliable. The combined use of both can increase the early diagnostic rate.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the role of serum prostate specific antigen (PSA) and prostate specific antigen density (PSAD) in the diagnosis of prostate carcinoma.Methods: PSA and PSAD by means of ELISA technique were assayed and compared in 20 prostate carcinoma patients and in 30 benign prostatic hyperplasia.Results: When the upper normal limit of PSA was set at 4ng/ml, the diagnosic sensitivity was 90.0%, the specificity 53.3% and the accuracy 68.0% in prostate carcinoma. If the upper normal limit of PSA was set at 10ng/ml, the sensitivity,specificity and the accuracy were 80.0%,83.3% and 82.0% respectively. The diagnosis sensitivity of PSAD was 85.0%, the specificity 86.7% and the accuracy 86.0%.Conclusion: PSA assay is the important means to discover prostate carcinoma and PSAD seems to be more reliable. The combined use of both can increase the early diagnostic rate.
Key concepts: Medicine, Prostate-specific antigen, Prostate, Urology, Hyperplasia, Carcinoma, Antigen, Prostate cancer